CNQ · BNXT.CN
BioNxt Solutions Inc.
CA$0.26-CA$0.03 (-8.77%)
BioNxt Solutions Inc.’s quoted price sits in the lower half of its reported 52-week range, 69.77% below the high.
Loading market information…
CNQ · MLCO.CN · CAD
Stock price, earnings
Quote as of Oct 30, 2026, 01:30 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CAD. Historical prices are not a forecast.
More Life Company Corp.’s quoted price sits in the lower half of its reported 52-week range, 52.38% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow More Life Company Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
The More Life Co. Corp. is a biotechnology company, which engages in the provision of solutions to optimize human, animal, and plant health. Its patented technologies includes Quicksome™ and Quicksol™. The Quicksome™ patented technology utilizes proprietary formulations and stabilizing molecules to encapsulate and formulate active ingredients into product formats that, if successfully commercialized, could enhance the efficacy of molecule delivery across a variety of nutraceutical product applications. The Quicksol™ patented is a solubilization technology, which has been developed to provide solubilized drug delivery options. The company was founded on March 8, 2005 and is headquartered in Vaughan, Canada.
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:07 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CA$0.26-CA$0.03 (-8.77%)
BioNxt Solutions Inc.’s quoted price sits in the lower half of its reported 52-week range, 69.77% below the high.
CA$0.07CA$0.00 (0.0%)
MediPharm Labs Corp.’s quoted price sits in the lower half of its reported 52-week range, 35.0% below the high.
CA$0.11-CA$0.01 (-4.55%)
Rapid Dose Therapeutics Corp.’s quoted price sits in the lower half of its reported 52-week range, 44.74% below the high.
CA$0.02-CA$0.00 (0.0%)
PreveCeutical Medical Inc.’s quoted price sits in the lower half of its reported 52-week range, 60.0% below the high.
CA$0.02+CA$0.01 (+33.33%)
Revive Therapeutics Ltd.’s quoted price sits in the lower half of its reported 52-week range, 75.0% below the high.
CA$1.90CA$0.00 (0.0%)
InnoCan Pharma Corporation’s quoted price sits in the lower half of its reported 52-week range, 90.08% below the high.
CA$0.04-CA$0.00 (0.0%)
Glow Lifetech Corp.’s quoted price sits in the lower half of its reported 52-week range, 38.46% below the high.
CA$0.02CA$0.00 (0.0%)
Nextleaf Solutions Ltd.’s quoted price sits in the lower half of its reported 52-week range, 76.47% below the high.
